Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer
Clinical trial NCT03016338 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03016338
- Sponsor
- University Health Network, Toronto
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-06
- Primary completion
- 2021-01-05
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.